亚太心脏移植市场预测至 2030 年 - 区域分析 - 按手术类型(原位心脏移植和异位心脏移植)、类型(供体活体心脏和人工心脏)和最终用户(医院、心脏中心等)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 70    |    Report Code: BMIRE00030079    |    Category: Life Sciences

Asia Pacific Heart Transplant Market
预计亚太地区心脏移植市场规模将从 2022 年的 34.2568 亿美元增长到 2030 年的 77.3974 亿美元。预计 2022 年至 2030 年的复合年增长率为 10.7%。

老年人口增长推动亚太地区心脏移植市场发展

老年人口易患心血管疾病、骨科疾病、代谢性疾病和神经系统疾病等。据世界卫生组织称,全球老龄人口可能会从 2019 年的约 10 亿增加到 2050 年的约 21 亿。中国和印度人口均超过 10 亿,截至 2020 年,亚洲人口超过 45 亿,占世界总人口的一半以上。预计亚洲人口数量为 4.14 亿,比 65 岁或以上的美国人(3.314 亿)多出约 20%。到 2050 年,预计亚洲老年人口将超过 9.23 亿。因此,老年人口的增长以及心力衰竭患病率的上升推动了心脏移植市场的增长。

亚太心脏移植市场概况

亚太心脏移植市场分为中国、印度、日本、韩国、澳大利亚和亚太其他地区。预计在预测期内,亚太地区的复合年增长率将位居全球市场之首。该地区市场的增长归因于医疗保健部门对器官捐赠重要性的认识提高,以及社交媒体营销的激增,以鼓励人们对器官捐赠持积极态度。此外,医疗保健基础设施的进步和增加投资以提高制造能力预计将在预测期内推动亚太心脏移植市场的发展。根据 BioMed Central 发表的一篇文章,中国超过 40% 的死亡归因于心血管疾病。此外,2019 年,中国约有 1.2033 亿人患有心血管疾病。快速的社会经济进步正在影响中国人口的生活方式,进而增加了感染心血管疾病(心脏或血管疾病)的机会,这些疾病可能导致心力衰竭。目前,心脏移植是晚期心力衰竭唯一已知的有效治疗方法。然而,由于心脏捐赠者数量有限,中国每年仅进行约 300 例心脏移植。因此,由于心脏移植的等待名单很长,患有心力衰竭的人选择人工心脏移植。

亚太心脏移植市场收入及预测至 2030 年(百万美元)

亚太心脏移植市场细分

亚太心脏移植市场细分为手术类型、类型、最终用户和国家。

根据手术类型,亚太心脏移植市场分为原位心脏移植和异位心脏移植。 2022 年,原位心脏移植部分在亚太心脏移植市场中占有较大份额。

就类型而言,亚太心脏移植市场分为供体活体心脏和人工心脏。2022 年,供体活体心脏部分在亚太心脏移植市场中占有较大份额。此外,人工心脏部分分为心室辅助装置和全人工心脏。

根据最终用户,亚太心脏移植市场分为医院、心脏中心和其他。2022 年,医院部分在亚太心脏移植市场中占有最大份额。

根据国家/地区,亚太心脏移植市场分为中国、印度、韩国、日本、澳大利亚和亚太其他地区。 2022 年,中国在亚太心脏移植市场占据主导地位。

Terumo Corp、Abbott Laboratories、SynCardia Systems LLC、BiVACOR Inc、BioVentrix Inc 和 LivaNova Plc 是亚太心脏移植市场的一些领先公司。

Asia Pacific Heart Transplant Strategic Insights

Strategic insights for Asia Pacific Heart Transplant involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-heart-transplant-market-strategic-framework.webp
Get more information on this report

Asia Pacific Heart Transplant Report Scope

Report Attribute Details
Market size in 2022 US$ 3,425.68 Million
Market Size by 2030 US$ 7,739.74 Million
Global CAGR (2022 - 2030) 10.7%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 手术类型
  • 原位心脏移植和异位心脏移植
By 类型
  • 供体活体心脏和人工心脏
By 最终用户
  • 医院
  • 心脏中心
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Terumo Corp
  • Abbott Laboratories
  • SynCardia Systems LLC
  • BiVACOR Inc
  • BioVentrix Inc
  • LivaNova Plc
  • Get more information on this report

    Asia Pacific Heart Transplant Regional Insights

    The regional scope of Asia Pacific Heart Transplant refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-heart-transplant-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Heart Transplant Market

    1. Terumo Corp

     

    2. Abbott Laboratories

    3. SynCardia Systems LLC

    4. BiVACOR Inc

    5. BioVentrix Inc

    6. LivaNova Plc

     

    Frequently Asked Questions
    How big is the Asia Pacific Heart Transplant Market?

    The Asia Pacific Heart Transplant Market is valued at US$ 3,425.68 Million in 2022, it is projected to reach US$ 7,739.74 Million by 2030.

    What is the CAGR for Asia Pacific Heart Transplant Market by (2022 - 2030)?

    As per our report Asia Pacific Heart Transplant Market, the market size is valued at US$ 3,425.68 Million in 2022, projecting it to reach US$ 7,739.74 Million by 2030. This translates to a CAGR of approximately 10.7% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Heart Transplant Market report typically cover these key segments-

  • 手术类型 (原位心脏移植和异位心脏移植)
  • 类型 (供体活体心脏和人工心脏)
  • 最终用户 (医院, 心脏中心)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Heart Transplant Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Heart Transplant Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Asia Pacific Heart Transplant Market?

    The Asia Pacific Heart Transplant Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Terumo Corp
  • Abbott Laboratories
  • SynCardia Systems LLC
  • BiVACOR Inc
  • BioVentrix Inc
  • LivaNova Plc
  • Who should buy this report?

    The Asia Pacific Heart Transplant Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Heart Transplant Market value chain can benefit from the information contained in a comprehensive market report.